Skip to content

Juvenile Idiopathic Inflammatory Myopathy C5679857

Published: July 22, 2026Updated: August 20, 2026

A group of disorders causing muscle inflammation and skin changes in children. Treatment typically involves corticosteroids and immunosuppressants along with physical therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
M35.9
ICD-11
FA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Difficulty swallowing

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle weakness

(musculoskeletal)

Skin rash

(musculoskeletal)

Joint pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corticosteroids and immunosuppressants

High-dose corticosteroids for acute inflammation followed by steroid-sparing immunosuppressants for long-term management. These medications suppress the abnormal immune response causing muscle inflammation.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Graduated exercise and rehabilitation program

Supervised exercise program starting with gentle range of motion and progressing to strength training as inflammation subsides. Helps maintain muscle function and prevent contractures.

physical_therapy

Additional treatment options

Nutritional support and calcium supplementation

Adequate protein intake supports muscle recovery while calcium and vitamin D supplementation helps protect bone health during corticosteroid therapy. Balanced diet supports overall healing.

dietary

Energy conservation and fatigue management

Learning to pace activities and schedule rest breaks helps manage chronic fatigue associated with inflammatory myopathy. Assistive devices may be helpful during flares.

lifestyle

Muscle strength and function monitoring

Regular assessment of muscle strength using standardized scales and functional tests to track disease progression and treatment response. Laboratory monitoring for muscle enzymes.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Juvenile Idiopathic Inflammatory Myopathy C5679857?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. Ann Rheum Dis. 2021.

guideline2021
2

Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2022.

review2022
3

Spencer CH, Rouster-Stevens K, Gewanter H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral corticosteroids in juvenile dermatomyositis. Arthritis Rheumatol. 2020.

clinical_trial2020
4

Wang H, Liu J, Chen R, et al. Efficacy and safety of biologic agents in juvenile idiopathic inflammatory myopathies: a systematic review and meta-analysis. Rheumatology (Oxford). 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Juvenile Idiopathic Inflammatory Myopathy C5679857. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy